{"url_path":"/sec/vani/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-000852-index.html","accession_number":"0001753926-26-000852","cik":"0001266806","ticker":"VANI","issuer_name":"Vivani Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-000852-index.html","primary_entity_key":"0001266806","primary_entity_name":"Vivani Medical, Inc."},"word_count":396,"has_tables":true,"body_markdown":"Item 6.  Exhibits\n\n \n\nEXHIBIT INDEX\n\n \n\nExhibit No.\n\nExhibit Description\n\n \n\n[3.1](http://www.sec.gov/Archives/edgar/data/1266806/000175392623000914/g083637_ex3-1.htm)\n\n[Certificate of Incorporation of Vivani Medical, Inc., filed with the Secretary of State of Delaware and effective, July 6, 2023 (incorporated by reference to Exhibit 3.1 in the Registrant’s Current Report on Form 8-K filed with the SEC on July 10, 2023).](http://www.sec.gov/Archives/edgar/data/1266806/000175392623000914/g083637_ex3-1.htm)\n\n \n\n[3.2](http://www.sec.gov/Archives/edgar/data/1266806/000175392623000914/g083637_ex3-2.htm)\n\n[Bylaws of Vivani Medical, Inc. effective July 6, 2023 (incorporated by reference to Exhibit 3.2 in the Registrant’s Current Report on Form 8-K filed with the SEC on July 10, 2023).](http://www.sec.gov/Archives/edgar/data/1266806/000175392623000914/g083637_ex3-2.htm)\n\n \n\n[10.1](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/ex101_2.htm)\n\n[Share Purchase Agreement, dated January 25, 2026, between the Registrant and the Purchaser named therein (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 27, 2026).](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/ex101_2.htm)\n\n \n\n[10.2](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/ex102_3.htm)\n\n[Placement Agency Agreement dated January 25, 2026 (incorporated by reference to Exhibit 10.21 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 27, 2026).](https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/ex102_3.htm)\n\n \n\n \n\n[31.1*](ex311_1.htm)\n\n[Certification of Principal Executive Officer of Vivani Medical, Inc. pursuant to Section 302 of Sarbanes-Oxley Act of 2002.](ex311_1.htm)\n\n \n\n \n\n[31.2*](ex312_2.htm)\n\n[Certification of Principal Financial and Accounting Officer of Vivani Medical, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex312_2.htm)\n\n \n\n \n\n[32.1**](ex321_3.htm)\n\n[Certifications of Principal Executive Officer and Principal Financial and Accounting Officer of Vivani Medical, Inc. pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex321_3.htm)\n\n  \n\n101.INS*\n\nInline XBRL Instance Document.\n\n \n\n101.SCH*\n\nInline XBRL Taxonomy Extension Schema with Embedded Linkbase Document.\n\n \n\n104*\n\nCover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibit 101)\n\n \n\n*\n\nFiled herewith.\n\n \n\n**\n\nThis certification will not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.\n\n \n\n69\n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n \n\nVivani Medical, Inc.\n\n \n\nDate: May 13, 2026\n\n \n\nBy:\n\n/s/ Adam Mendelsohn\n\n \n\n \n\n \n\n \n\nChief Executive Officer\n\n \n\n \n\n \n\n \n\n(Principle Executive Officer)\n\n \n\n \n\n \n\n \n\n \n\n \n\nDate: May 13, 2026\n\n \n\nBy:\n\n/s/ Anthony Baldor\n\n \n\n \n\n \n\n \n\nChief Financial Officer\n\n \n\n \n\n \n\n \n\n(principle financial officer)\n\n \n\n \n\n70"}